SCHEMBL12199488

SCHEMBL12199488

Cc1ccc(C(c2ccccc2)(c2ccc(C)cc2)N2CCCCC2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2B6 P20813 1/20 0.56
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
KIF11 P52732 3/20 0.39
LMNA P02545 3/20 0.38
POLB P06746 1/20 0.38
CHRM2 P08172 3/20 0.38
HTR1A P08908 3/20 0.38
CHRM1 P11229 3/20 0.38
OPRM1 P35372 3/20 0.38
KCNH2 Q12809 3/20 0.38
CYP2D6 P10635 2/20 0.38
HRH1 P35367 1/20 0.37
MAPK1 P28482 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
DRD1 P21728 2/20 0.36
ACHE P22303 2/20 0.36
DRD3 P35462 2/20 0.36
ALDH1A1 P00352 1/20 0.36
ADRA2A P08913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2489520 1.00 CYP2B6 (0.56) CYP2B6MEN1KMT2AKIF11LMNA
SCHEMBL2494381 0.92 CYP2B6 (0.44) CYP2B6MEN1KMT2AHRH1ALDH1A1
SCHEMBL2488720 0.90 TSHR (0.42) CYP2B6MEN1KMT2APOLBHRH1
SCHEMBL12199479 0.89 CYP2B6 (0.46) CYP2B6MEN1KMT2AKIF11LMNA
SCHEMBL2491599 0.88 CYP2B6 (0.63) CYP2B6MEN1KMT2ALMNACHRM2
SCHEMBL19296941 0.88 CYP2B6 (0.63) CYP2B6MEN1KMT2ALMNACHRM2
SCHEMBL2392136 0.86 CYP2B6 (0.59) CYP2B6MEN1KMT2ALMNACHRM2
SCHEMBL12209773 0.81 CYP2B6 (0.51) CYP2B6MEN1KMT2AKIF11LMNA
SCHEMBL18812947 0.81 KCNA3 (0.41) MEN1KMT2ALMNAKCNH2HRH1
SCHEMBL2490819 0.81 CYP2B6 (0.51) CYP2B6MEN1KMT2AKIF11LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10568822-B2 Melanogenesis inhibitor comprising d-pantothenyl alcohol, and skin-whitening cosmetic containing same melanogenesis inhibitor POLA CHEMICAL INDUSTRIES, INC. (JP) 2020-02-25 US disclosed
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
US-20170119638-A1 MELANOGENESIS INHIBITOR COMPRISING D-PANTOTHENYL ALCOHOL, AND SKIN-WHITENING COSMETIC CONTAINING SAME MELANOGENESIS INHIBITOR POLA CHEMICAL INDUSTRIES, INC. (JP) 2017-05-04 US disclosed
US-20170119638-A1 MELANOGENESIS INHIBITOR COMPRISING D-PANTOTHENYL ALCOHOL, AND SKIN-WHITENING COSMETIC CONTAINING SAME MELANOGENESIS INHIBITOR POLA CHEMICAL INDUSTRIES, INC. (JP) 2017-05-04 US disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170119638-A1 MELANOGENESIS INHIBITOR COMPRISING D-PANTOTHENYL ALCOHOL, AND SKIN-WHITENING COSMETIC CONTAINING SAME MELANOGENESIS INHIBITOR MC1R, TYR, NAMPT CYP2B6 1046/4885MEN1 2367/4885KMT2A 632/4885
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH CYP2B6 105/4885MEN1 1585/4885KMT2A 2108/4885
US-10568822-B2 Melanogenesis inhibitor comprising d-pantothenyl alcohol, and skin-whitening cosmetic containing same melanogenesis inhibitor MC1R, TYR, NAMPT CYP2B6 1046/4885MEN1 2367/4885KMT2A 632/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 CYP2B6 100/4885MEN1 1346/4885KMT2A 2219/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R CYP2B6 110/4885MEN1 1200/4885KMT2A 2287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.